Sun Pharma net profit rises 11 percent to Rs 2,058.8 crore in Q3
Advertisement
New Delhi: Sun Pharma on Monday posted an 11.14 per cent increase in its consolidated net profit to Rs 2,058.8 crore for the third quarter ended on December 31, 2021, on the back of robust sales across domestic and international markets.
The Mumbai-based drug major had reported a consolidated net profit of Rs 1,852.4 crore in the October-December period of previous fiscal.
Total revenue from operations rose to Rs 9,863 crore in the third quarter as compared to Rs 8,836.7 crore in the same period of previous fiscal, Sun Pharmaceutical Industries said in a regulatory filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.